Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-10-03 | 2017-11-07 | 24280 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-10-03 | 2017-11-07 | 24283 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2018-01-10 | 2018-05-04 | 35548 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2018-01-18 | 2018-05-01 | 36438 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-01-31 | 2018-05-09 | 37737 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-10-25 | 2018-11-22 | 65602 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-12-05 | 2019-12-23 | 100314 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-12-11 | 2021-01-11 | 130065 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-03-19 | 2021-05-03 | 136030 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-04-09 | 2021-04-19 | 137267 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-05-25 | 2021-06-28 | 139851 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2021-07-09 | 2021-10-05 | 142280 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2021-08-16 | 2021-09-27 | 144186 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144189 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2021-08-16 | 2021-10-05 | 144204 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-02-25 | 2022-03-25 | 155606 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-02-25 | 2022-03-28 | 155609 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2022-09-23 | 2022-11-04 | 170112 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2022-10-07 | 2022-11-04 | 171427 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2022-11-11 | 2023-01-21 | 174329 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LAMIVUDINE | 300MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60560 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Discontinued | 2018-09-07 | 2019-12-21 | 60563 |
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-LEVOCARB | 25MG 250MG | TABLET | Discontinued | 2018-09-07 | 2019-02-07 | 60576 |
| APO-LISINOPRIL | 10MG | TABLET | Discontinued | 2018-09-07 | 2019-02-02 | 60579 |
| APO-LISINOPRIL | 20MG | TABLET | Discontinued | 2018-09-07 | 2018-11-26 | 60582 |
| APO-LISINOPRIL | 5MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60585 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-LISINOPRIL/HCTZ | 25MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1096 |
| APO-LITHIUM CARBONATE | 300MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60588 |
| APO-LOPERAMIDE | 2MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4930 |
| APO-LORAZEPAM | 0.5MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60591 |
| APO-LORAZEPAM | 1MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60594 |
| APO-LOSARTAN | 50MG | TABLET | Discontinued | 2018-09-10 | 2018-09-15 | 60987 |
| APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
| APO-LOSARTAN | 25MG | TABLET | Discontinued | 2019-02-01 | 2019-02-02 | 74376 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-11-02 | 60597 |
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60600 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |